Research & Education
CURE Expert Connections
To start your customized experience click the start button
Cancer of Unknown Primary
Diet and Exercise
Gastrointestinal stromal tumor
General Financial Topics
General Psychosocial Aspect Topics
Head & Neck Cancer
MDS and MPN
Side Effect Management
Advocacy & Research
Share Your Story
Newsletter Sign Up
Ovarian Cancer Heroes
Terms & Conditions
Cure Media Group, LLC.
2 Clarke Drive
Cranbury, NJ 08512
Copyright © 2017
CURE Communications Group.
All rights reserved.
Cure Media Group, LLC. All Rights Reserved.
CURE does not provide medical, diagnostic, or treatment advice.
Whispering Hope: Treatment for CLL
Ed chronicles part II of his chronic lymphocytic leukemia (CLL) story from the third person.
New Agent Shows Promise Over Imbruvica in Treatment of CLL
In an interview with CURE, John C. Byrd discusses the efficacy of acalabrutinib and how it compares with Imbruvica.
Next-Generation Drug Challenging Imbruvica in Chronic Lymphocytic Leukemia
Anita T. Shaffer
Less than two years after Imbruvica gained approval for patients with CLL, a second-generation agent has demonstrated a 95 percent response rate.
Frontline Imbruvica Improves Survival in Chronic Lymphocytic Leukemia
Beth Fand Incollingo
The results showed a two-year overall survival rate of 98 percent with Imbruvica.
William G. Wierda on the Treatment of CLL
William G. Wierda
CURE spoke with Wierda at the 2015 Chemotherapy Foundation Symposium, a meeting of over 1,000 oncologists and oncology professionals.
Gaining a Fuller Understanding of Neurotoxicity From CAR T Cell Therapy
Andrew J. Roth
Though clinical work is ongoing and early, researchers are already considering how to manage potentially fatal neurotoxicities in patients treated with chimeric antigen receptor (CAR) T-cell therapy.
Positive Data Stops Phase 3 CLL Study of Zydelig
A phase 3 study exploring Zydelig in combination with Treanda and Rituxan for patients with previously treated CLL has been stopped early following a positive interim analysis.
Ed chronicles his chronic lymphocytic leukemia (CLL) story from the third person.
Connecting Healthy Adults to People With Blood Cancers
By donating stem cells through Be The Match, healthy adults can save the lives of people with blood cancers.
New Treatments May Be Worth the Wait in CLL
Watching, waiting and then choosing from a bevy of new treatments can be a good strategy for many with CLL.
Not a member?
Sign up now!
Continue without login
OPTIONAL INFORMATION: The following information helps us tailor CURE to fit your needs
Please type below what best describes your interests and click on the selection(s):
What is your status?
Out of Treatment